Cell therapy for pain

Expert Opinion on Biological Therapy

Volumn 8, Issue 12, 2008, Pages 1847-1853

  Jain, K K ^a  

^a JAIN PHARMABIOTECH   (Switzerland)

Author keywords

Cancer pain; Cell therapy; Chronic pain; Drug delivery for pain; Encapsulated cells; Gene therapy; Genetically modified cells; Neuropathic pain; Pain; Stem cells

Indexed keywords

ANALGESIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; ENKEPHALIN; OSTEOGENIC PROTEIN 1; PREPROENKEPHALIN;

ANTINOCICEPTION; ASTROCYTE; CANCER PAIN; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL FUNCTION; CELL ISOLATION; CELL SECRETION; CELL THERAPY; CELL TRANSPLANTATION; CHROMAFFIN CELL; CHRONIC PAIN; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG DELIVERY SYSTEM; EXPRESSION VECTOR; GENE DELIVERY SYSTEM; HUMAN; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISKECTOMY; KNEE PAIN; LOW BACK PAIN; LOW DRUG DOSE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEOPLASM; NEURAL STEM CELL; NEUROPATHIC PAIN; NONHUMAN; PHENOTYPE; PHYSIOTHERAPY; QUALITY OF LIFE; REVIEW; SAFETY;

ANALGESICS; ANIMALS; CHROMAFFIN CELLS; PAIN; STEM CELLS; TISSUE THERAPY;

ANIMALIA;

EID: 57649197974     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712590802496951     Document Type: Review

References (30)

1. Jain KK. Pain therapeutics - drugs, markets and companies. Jain PharmaBiotech Publications, Basel, 2008. Available from: http://pharmabiotech.ch/reports/pain [Last accessed October 4 2008]
2. Jain KK. Gene therapy for pain. Expert Opin Biol Ther 2008; In press
3. Jain KK. Cell therapy: technologies, markets and companies, Jain PharmaBiotech Publications, Basel, 2008. Available from: http://pharmabiotech.ch/reports/celltherapy [Last accessed October 4 2008]
4. Winn SR. Emerich DF. Managing chronic pain with encapsulated cell implants releasing catecholamines and endogenous opiods. Front Biosci 2005;10:367-78
5. Jeon Y, Kwak K, Kim S, et al. Intrathecal implants of microencapsulated xenogenic chromaffin cells provide a long-term source of analgesic substances. Transplant Proc 2006;38:3061-5
6. Moustafa T, Girod S, Tortosa F, et al. Viability and functionality of bovine chromaffin cells encapsulated into alginate-PLL microcapsules with a liquefied inner core. Cell Transplant 2006;15:121-33
7. Sol JC, Li RY, Sallerin B, et al. Intrathecal grafting of porcine chromaffin cells reduces formalin-evoked c-Fos expression in the rat spinal cord. Cell Transplant 2005;14:353-65
8. Kim YM, Jeon YH, Jin CC, et al. Immunoisolated chromaffin cells implanted into the subarachnoid space of rats reduce cold allodynia in a model of neuropathic pain: a novel application of microencapsulation technology. Artif Organs 2004;28:1059-66
9. Duplan H, Li RY, Vue C, et al. Grafts of immortalized chromaffin cells bio-engineered to improve met-enkephalin release also reduce formalin-evoked c-fos expression in rat spinal cord. Neurosci Lett 2004;370:1-6
10. Zhou H, Aziza J, Sol JC, et al. Cell therapy of pain: Characterization of human fetal chromaffin cells at early adrenal medulla development. Exp Neurol 2006;198:370-81
11. Jozan S, Aziza J, Châtelin S, et al. Human fetal chromaffin cells: a potential tool for cell pain therapy. Exp Neurol 2007;205:525-35
12. Xu Y, Tian XB, An K, et al. Lumbar transplantation of immortalized enkephalin-expressing astrocytes attenuates chronic neuropathic pain. Eur J Pain 2008;12:525-33
13. Baghbaderani BA, Mukhida K, Sen A, et al. Expansion of human neural precursor cells in large-scale bioreactors for the treatment of neurodegenerative disorders Biotechnol Prog 2008;24:859-70
14. Mukhida K, Mendez I, McLeod M, et al. Spinal GABAergic transplants attenuate mechanical allodynia in a rat model of neuropathic pain. Stem Cells 2007;25:2874-85
15. Sugaya I, Qu T, Sugaya K, Pappas GD. Genetically engineered human mesenchymal stem cells produce met-enkephalin at augmented higher levels in vitro Cell Transplant 2006;15:225-30
16. Shi G, Ma K, Pappas GD, Qu T. Phenotypic characteristics of hybrid cells produced by cell fusion of porcine adrenal chromaffin cells with human mesenchymal stem cells: a preliminary study. Neurol Res 2008;30:217-22
17. Eaton MJ, Plunkett JA, Martinez MA, et al. Transplants of neuronal cells bioengineered to synthesize GABA alleviate chronic neuropathic pain. Cell Transplant 1999;8:87-101
18. Gajavelli S, Castellanos DA, Furmanski O, et al. Sustained analgesic peptide secretion and cell labeling using a novel genetic modification. Cell Transplant 2008;17:445-55
19. Hagihara Y, Saitoh Y, Arita N, et al. Long-term functional assessment of encapsulated cells transfected with Tet-On system. Cell Transplant 1999;8:431-4
20. Zhang Y, Phillips FM, Thonar EJ, et al. Cell therapy using articular chondrocytes overexpressing BMP-7 or BMP-10 in a rabbit disc organ culture model. Spine 2008;33:831-8
21. Meisel HJ, Siodla V, Ganey T, et al. Clinical experience in cell-based therapeutics: disc chondrocyte transplantation A treatment for degenerated or damaged intervertebral disc. Biomol Eng 2007;24:5-21
22. Richardson SM, Hoyland JA. Stem cell regeneration of degenerated intervertebral discs: current status. Curr Pain Headache Rep 2008;12:83-8
23. Jandial R, Aryan HE, Park J, et al. Stem cell-mediated regeneration of the intervertebral disc: cellular and molecular challenge. Neurosurg Focus 2008;24(3-4):E21
24. Sheyn D, Pelled G, Zilberman Y, et al. Nonvirally engineered porcine adipose tissue-derived stem cells: use in posterior spinal fusion. Stem Cells 2008;26:1056-64
25. Richter W. Cell-based cartilage repair: illusion or solution for osteoarthritis. Curr Opin Rheumatol 2007;19:451-6
26. Centeno CJ, Busse D, Kisiday J, et al. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 2008;11:343-53
27. Jain KK. Current challenges and future prospects in management of neuropathic pain. Expert Rev Neurother 2008;8:1735-48
28. Cejas PJ, Martinez M, Karmally S, et al. Lumbar transplant of neurons genetically modified to secrete brain-derived neurotrophic factor attenuates allodynia and hyperalgesia after sciatic nerve constriction. Pain 2000;86(1-2):195-210
29. Klass M, Gavrikov V, Drury D, et al. Intravenous mononuclear marrow cells reverse neuropathic pain from experimental mononeuropathy. Anesth Analg 2007;104:944-8
30. Lazorthes Y, Sagen J, Sallerin B, et al. Human chromaffin cell graft into the CSF for cancer pain management: a prospective Phase II clinical study. Pain 2000;87:19-32